Phase 1 Trial of ASTX727 in Subjects With Lower-risk Myelodysplastic Syndromes
Clinical trial NCT03906695 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03906695
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-15
- Primary completion
- 2026-01-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.